【摘要】 目的 探讨分子吸附再循环系统(MARS)人工肝在治疗慢性重型肝炎肝肾综合征中的临床价值和护理体会。 方法 44例慢性重型肝炎肝肾综合征患者随机分为治疗组和对照组，治疗组在内科综合治疗基础上予MARS人工肝治疗。治疗前后检测肝肾功能、电解质等。 结果 MARS治疗组与对照组患者的2周存活率分别为72.7%和18.2%，差异有非常显著性(P<0.01)，治疗组与对照组在治疗后血清胆红素、尿素、肌酐、钾、钠差异有非常显著性(P<0.01)，治疗组血清胆红素、尿素、肌酐明显下降，低钾低钠得以纠正，MARS治疗过程中，血液相容性好，无明显副作用。 结论 MARS人工肝是治疗慢性重型肝炎肝肾综合征的安全有效方法。

    关键词 分子吸附再循环系统 人工肝 慢性重型肝炎 肝肾综合征

    Effects of molecular adsorbent recirculating system artificial liver on chronic severe hepatitis with hepatorenal syndrome and its nursing

    Tang Jihua

    The Second Hospital of Nanjing Affiliated to Medical Institute of Southeast University，Jiangsu210003.

    【Abstract】 Objective To explore the clinical value of molecular adsorbent recirculating system(MARS)artifi-cial liver in the management of chronic severe hepatitis with hepatorenal syndrome and its nursing.Methods 44patients with chronic hepatitis with hepatorenal syndrome were randomized into two groups ......